Two large clinical trials were presented in the late-breaking clinical trials session at the American College of Cardiology's (ACC) 61st Annual Scientific Session this week that indicate coronary computed tomography angiography (CCTA) used as a tool to evaluate patients with chest pain in the emergency department is safe, time-efficient and cost-effective, compared to the current standard approach.


Agfa HealthCare's new modular version of its cardiovascular information system (CVIS), Impax CV12, was unveiled at the American College of Cardiology (ACC) Annual Scientific Session this week in Chicago. 

GE Healthcare unveiled two recently U.S. Food and Drug Administration (FDA)-cleared angiography systems offering mobility and advanced imaging for interventional cardiology at the American College of Cardiology (ACC) 2012. 


New evidence shows that with appropriate preparation, angioplasty can be safely and effectively performed at community hospitals without on-site cardiac surgery units. This was according to data presented from the CPORT-E trial during the American College of Cardiology's (ACC) 61st Annual Scientific Session this week in Chicago. 



Coronary angiography is unable to accurately predict the severity of vessel narrowing, suggesting fractional flow reserve (FFR) functional tests should be added to help determine if a patient needs revascularization. This was according to research presented from the IRIS FFR-DEFER trial at the American College of Cardiology's (ACC) 61st Annual Scientific Session this week in Chicago.



The cost to place an implantable cardioverter-defibrillator (ICD) increased by $844 per case after a new requirement from the Centers for Medicare and Medicaid Services (CMS) went into effect in February 2010, which has added little additional benefit for patients. This was according to research presented during the American College of Cardiology’s 61st Annual Scientific Session in Chicago this week.



March 27, 2012 – Researchers found the antiplatelet drug abciximab significantly decreased damage to the heart muscle in patients with ST-segment-elevation myocardial infarction (STEMI), the most severe type of heart attack. Results of INFUSE-AMI trial were presented at the American College of Cardiology’s 61st Annual Scientific Session and published simultaneously in the March 25 online issue of the Journal of the American Medical Association. Researchers also found that clot aspiration did not significantly reduce the damage to the heart muscle.



Biodegradable polymer drug-eluting stents (DES) provide better long-term safety and efficacy than durable polymer DES, according to findings from an analysis of three major clinical trials — ISAR-TEST 3, ISAR-TEST 4 and LEADERS. The data were presented at at the American College of Cardiology’s 61st Annual Scientific Session.


March 26, 2012 — ScImage Inc. launched a new cloud electrocardiogram (ECG) management service as an extension of its PicomCloud cloud picture archiving and communications system (PACS) at the American College of Cardiology's (ACC) 61st Annual Scientific Session in Chicago.

Subscribe Now